Lifecore Biomedical, Inc.
NASDAQ: LFCR0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Paul Josephs
- Employees
- 403
- Headquarters
- Chaska, United States
- IPO year
- 1996
- Market cap
- $217.6M
- Website
- https://www.lifecore.com
Loading LFCR…
Loading profile data…Frequently asked questions about LFCR
What does Lifecore Biomedical, Inc. (LFCR) do?
Lifecore Biomedical, Inc., together with its subsidiaries, operates as an integrated contract development and manufacturing organization that serves customers in the United States, Belgium, the Netherlands, and internationally. It provides services in the development, manufacture, aseptic fill, and finish of formulations and highly viscous steri...
Where does LFCR trade?
Lifecore Biomedical, Inc. (LFCR) trades on the NASDAQ.
What sector is LFCR in?
Lifecore Biomedical, Inc. (LFCR) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Lifecore Biomedical, Inc.?
Paul Josephs is the chief executive officer of Lifecore Biomedical, Inc. (LFCR).
Where is Lifecore Biomedical, Inc. headquartered?
Lifecore Biomedical, Inc. is headquartered in United States.
Does LFCR pay a dividend?
Lifecore Biomedical, Inc. (LFCR) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did LFCR go public?
Lifecore Biomedical, Inc. (LFCR) completed its initial public offering in 1996.